AG
BHC icon

Aperio Group’s Bausch Health BHC Stock Holding History

Aperio Group’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.81M Sell
134,999
-90,655
-40% -$1.69M 0.01% 1076
2020
Q3 		$3.51M Sell
225,654
-38,409
-15% -$662K 0.01% 873
2020
Q2 		$4.83M Buy
264,063
+60,445
+30% +$1.07M 0.02% 745
2020
Q1 		$3.16M Buy
203,618
+7,439
+4% +$179K 0.01% 830
2019
Q4 		$5.87M Buy
196,179
+14,761
+8% +$384K 0.02% 679
2019
Q3 		$3.96M Sell
181,418
-9,401
-5% -$215K 0.02% 784
2019
Q2 		$4.81M Sell
190,819
-9,465
-5% -$225K 0.02% 725
2019
Q1 		$4.95M Sell
200,284
-4,512
-2% -$108K 0.02% 708
2018
Q4 		$3.78M Buy
204,796
+7,120
+4% +$169K 0.02% 745
2018
Q3 		$5.07M Sell
197,676
-3,994
-2% -$91.5K 0.02% 681
2018
Q2 		$4.69M Buy
201,670
+7,504
+4% +$155K 0.02% 689
2018
Q1 		$3.09M Sell
194,166
-15,455
-7% -$288K 0.02% 820
2017
Q4 		$4.36M Buy
209,621
+21,818
+12% +$346K 0.02% 685
2017
Q3 		$2.69M Buy
187,803
+65,424
+53% +$989K 0.02% 826
2017
Q2 		$2.12M Buy
122,379
+53,542
+78% +$642K 0.01% 887
2017
Q1 		$759K Buy
68,837
+43,842
+175% +$603K 0.01% 1300
2016
Q4 		$363K Sell
24,995
-9,964
-29% -$183K ﹤0.01% 1696
2016
Q3 		$858K Buy
34,959
+6,668
+24% +$173K 0.01% 1176
2016
Q2 		$570K Sell
28,291
-7,301
-21% -$207K ﹤0.01% 1320
2016
Q1 		$936K Sell
35,592
-9,776
-22% -$723K 0.01% 1072
2015
Q4 		$4.61M Sell
45,368
-17,173
-27% -$1.93M 0.04% 479
2015
Q3 		$11.2M Buy
62,541
+5,436
+10% +$1.27M 0.11% 207
2015
Q2 		$12.7M Buy
57,105
+5,863
+11% +$1.3M 0.13% 185
2015
Q1 		$10.2M Buy
51,242
+7,974
+18% +$1.41M 0.11% 217
2014
Q4 		$6.19M Buy
43,268
+11,648
+37% +$1.57M 0.08% 319
2014
Q3 		$4.15M Buy
31,620
+4,183
+15% +$499K 0.06% 400
2014
Q2 		$3.46M Sell
27,437
-1,710
-6% -$218K 0.05% 435
2014
Q1 		$3.84M Buy
+29,147
New +$3.99M 0.05% 458
2013
Q4 		– Sell
-20,677
Closed -$2.27M – 509
2013
Q3 		$2.16M Buy
20,677
+4,730
+30% +$461K 0.04% 561
2013
Q2 		$1.37M Buy
+15,947
New +$1.26M 0.03% 636

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aperio Group's BHC Position: Q4 2020 in Review

Aperio Group reduced its Bausch Health (BHC) stake by 40% in Q4 2020, selling an estimated $1.69M and leaving 134,999 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1076.

Aperio Group first reported a position in BHC in Q2 2013 and has held it in 30 quarters since. The position peaked at $12.7M in Q2 2015. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

  • Aperio Group held 134,999 shares of Bausch Health worth $2.81M as of Q4 2020.
  • Aperio Group sold 90,655 Bausch Health shares in Q4 2020, an estimated $1.69M.
  • Bausch Health made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1076 holding.
  • Aperio Group first reported a position in Bausch Health in Q2 2013 and has held it in 30 quarters since.
  • Aperio Group's Bausch Health position peaked at $12.7M in Q2 2015.
  • 338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.